Status
Conditions
Treatments
About
The purpose is the description of anti-tumor immune responses in general and according to clinical stage and disease free survival (DFS: survival without recurrence (local or distant)) in patients with Head & Neck Squamous Cell Carcinoma
Secondary purposes are:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
154 participants in 1 patient group
Loading...
Central trial contact
Marcelo DE CARVALHO; Patrice GALLET
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal